Frontlight ResearchEarly access
CompletedNo phase
ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients
Key facts
- Who runs it
- University of Aarhus
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 150 people enrolled
- Started
- 1 Dec 2019
- Ended
- 30 Nov 2023
- Type of study
- Observational
- Record updated
- 25 January 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Diagnosis of sarcoidosis
- Signed informed consent
Who cannot take part
- Inability or unwillingness to adhere to the study
- Inability to give informed consent
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficult to predict.
Read full original descriptionShow less
This study aims to evaluate the predictive value of ACE and HLA genotypes on disease severity and progression in Danish patients with sarcoidosis.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 25 January 2024